Impaired high-density lipoprotein anti-oxidant capacity in human abdominal aortic aneurysm

Cardiovascular Research

Volumn 100, Issue 2, 2013, Pages 307-315

  Delbosc, Sandrine ^a,b   Diallo, Devy ^a,b   Dejouvencel, Tiphaine ^a,b   Lamiral, Zohra ^c,e   Louedec, Liliane ^a,b   Martin Ventura, Jose Luis ^f   Rossignol, Patrick ^c,d   Leseche, Guy ^a,b   Michel, Jean Baptiste ^a,b,g   Meilhac, Olivier ^a,b,g  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Abdominal aortic aneurysm; Haemoglobin; High density lipoproteins; Oxidative stress

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE;

ABDOMINAL AORTA ANEURYSM; ADVENTITIA; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON CHELATION; LIPID OXIDATION; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; THROMBUS; WESTERN BLOTTING;

ABDOMINAL AORTIC ANEURYSM; HAEMOGLOBIN; HIGH-DENSITY LIPOPROTEINS; OXIDATIVE STRESS;

AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEIN A-I; APOPTOSIS; CELLS, CULTURED; HUMANS; LIPOPROTEINS, HDL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS; PARTICLE SIZE; PEROXIDASE; REACTIVE OXYGEN SPECIES;

EID: 84886054474     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt194     Document Type: Article

References (53)

1. Michel JB, Martin-Ventura JL, Egido J, Sakalihasan N, Treska V, Lindholt J et al. Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans. Cardiovasc Res 2011;90:18-27.
2. Michel JB, Thaunat O, Houard X, Meilhac O, Caligiuri G, Nicoletti A. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol 2007;27:1259-1268.
3. Li M, Fukagawa NK. Age-related changes in redox signaling and vsmc function. Antioxid Redox Signal 2010;12:641-655.
4. Sakalihasan N, Pincemail J, Defraigne JO, Nusgens B, Lapiere C, Limet R. Decrease of plasma vitamin e (alpha-tocopherol) levels in patients with abdominal aortic aneurysm. Ann N Y Acad Sci 1996;800:278-282.
5. Martin-Ventura JL, Madrigal-Matute J, Martinez-Pinna R, Ramos-Mozo P, Blanco-Colio LM, Moreno JA et al. Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: Detoxifying mechanisms and potential therapeutic options. Thromb Haemost 2012;108:435-442.
6. Miller FJ Jr, Sharp WJ, Fang X, Oberley LW, Oberley TD, Weintraub NL. Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler Thromb Vasc Biol 2002;22:560-565.
7. Ingueneau C, Huynh-Do U, Thiers JC, Negre-Salvayre A, Salvayre R, Vindis C. Caveolin-1 sensitizes vascular smooth muscle cells to mildly oxidized LDL-induced apoptosis. Biochem Biophys Res Commun 2008;369:889-893.
8. Li J, Li PF, Dietz R, von Harsdorf R. Intracellular superoxide induces apoptosis in VSMCs: role of mitochondrial membrane potential, cytochrome c and caspases. Apoptosis 2002; 7:511-517.
9. Kazi M, Thyberg J, Religa P, Roy J, Eriksson P, Hedin U et al. Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. J Vasc Surg 2003;38:1283-1292.
10. Koole D, Zandvoort HJ, Schoneveld A, Vink A, Vos JA, van den Hoogen LL et al. Intraluminal thrombus is associated with disruption of wall integrity. J Vasc Surg 2013;57: 77-83.
11. Fontaine V, Jacob MP, Houard X, Rossignol P, Plissonnier D, Angles-Cano E et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 2002;161:1701-1710.
12. Fontaine V, Touat Z, Mtairag el M, Vranckx R, Louedec L, Houard X et al. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am J Pathol 2004;164:2077-2087.
13. Kontush A, Chapman MJ. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 2006;58:342-374.
14. Tabet F, Rye KA. High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond) 2009;116:87-98.
15. Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol 2011;8:92-102.
16. Takagi H, Manabe H, Kawai N, Goto SN, Umemoto T. Serum high-density and lowdensity lipoprotein cholesterol is associated with abdominal aortic aneurysm presence: a systematic review and meta-analysis. Int Angiol 2010;29:371-375.
17. Golledge J, van Bockxmeer F, Jamrozik K, McCann M, Norman PE. Association between serum lipoproteins and abdominal aortic aneurysm. Am J Cardiol 2010;105:1480-1484.
18. Dejouvencel T, Feron D, Rossignol P, Sapoval M, Kauffmann C, Piot JM et al. Hemorphin 7 reflects hemoglobin proteolysis in abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2010;30:269-275.
19. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998;161:2524-2532.
20. Yagi K. Asimple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15:212-216.
21. Vega de Ceniga M, Blanco-Colio LM, Tunon J, Egido J, Martin-Ventura JL. Statin use in aortic aneurismal disease to prevent progression and cardiovascular events: Review of experimental and clinical data. Curr Vasc Pharmacol 2013;11:299-304.
22. Haas MJ, Mooradian AD. Inflammation, high-density lipoprotein and cardiovascular dysfunction. Curr Opin Infect Dis 2011;24:265-272.
23. Ortiz-Munoz G, Houard X, Martin-Ventura JL, Ishida BY, Loyau S, Rossignol P et al. HDL antielastase activity prevents smooth muscle cell anoikis, a potential newantiatherogenic property. FASEB J 2009;23:3129-3139.
24. Shao B, Oda MN, Bergt C, Fu X, Green PS, Brot N et al. Myeloperoxidase impairs abca1- dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. J Biol Chem 2006;281:9001-9004.
25. Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 2004;114:529-541.
26. McCormick ML, Gavrila D, Weintraub NL. Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2007;27:461-469.
27. Dubick MA, Keen CL, DiSilvestro RA, Eskelson CD, Ireton J, Hunter GC. Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc Soc Exp Biol Med 1999;220:39-45.
28. Ramos-Mozo P, Madrigal-Matute J, Martinez-Pinna R, Blanco-Colio LM, Lopez JA, Camafeita E et al. Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a novel biomarker of abdominal aortic aneurysm: Potential implication of oxidative stress in abdominal aortic aneurysm progression. Arterioscler Thromb Vasc Biol 2011; 31:3011-3019.
29. Morimoto K, Hasegawa T, Tanaka A, Wulan B, Yu J, Morimoto N et al. Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats. J Vasc Surg 2012;55:1749-1758.
30. Breton-Gorius J, Guichard J. Fine structural and cytochemical identification of microperoxisomes in developing human erythrocytic cells. Am J Pathol 1975;79:523-536.
31. Lee FY, Lee TS, Pan CC, Huang AL, Chau LY. Colocalization of iron and ceroid in human atherosclerotic lesions. Atherosclerosis 1998;138:281-288.
32. Haka AS, Kramer JR, Dasari RR, Fitzmaurice M. Mechanism of ceroid formation in atherosclerotic plaque: in situ studies using a combination of Raman and fluorescence spectroscopy. J Biomed Opt 2011;16:011011.
33. Meier P, Vogt B, Blanc E. Rethinking the triggering inflammatory processes of chronic periaortitis. Nephron Exp Nephrol 2007;105:e17-e23.
34. Lu N, Chen W, Peng YY. Effects of glutathione, trolox and desferrioxamine on hemoglobin-induced protein oxidative damage: anti-oxidant or pro-oxidant? Eur J Pharmacol 2011;659:95-101.
35. Song S, Hua Y, Keep RF, Hoff JT, Xi G. A new hippocampal model for examining intracerebral hemorrhage-related neuronal death: effects of deferoxamine on hemoglobininduced neuronal death. Stroke 2007;38:2861-2863.
36. Hayashi T, Uchida K, Takebe G, Takahashi K. Rapid formation of 4-hydroxy-2-nonenal, malondialdehyde, and phosphatidylcholine aldehyde from phospholipid hydroperoxide by hemoproteins. Free Radic Biol Med 2004;36:1025-1033.
37. Piechota-Polanczyk A, Goraca A, Demyanets S, Mittlboeck M, Domenig C, Neumayer C et al. Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via nf-kappab. Eur J Vasc Endovasc Surg 2012;44:133-137.
38. Krishna SM, Seto SW, Moxon JV, Rush C, Walker PJ, Norman PE et al. Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. Am J Pathol 2012; 181:706-718.
39. Torsney E, Pirianov G, Charolidi N, Shoreim A, Gaze D, Petrova S et al. Elevation of plasma high-density lipoproteins inhibits development of experimental abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2012;32:2678-2686.
40. Asztalos BF, Batista M, Horvath KV, Cox CE, Dallal GE, Morse JS et al. Change in alpha1 HDLconcentration predicts progression in coronary artery stenosis. Arterioscler Thromb Vasc Biol 2003;23:847-852.
41. Schaefer EJ, Asztalos BF. Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. Am J Cardiol 2007; 100:n25-n31.
42. Camont L, Chapman MJ, Kontush A. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol Med 2011;17:594-603.
43. Eren E, Yilmaz N, Aydin O. High density lipoprotein and it's dysfunction. Open Biochem J 2012;6:78-93.
44. Akishima Y, Akasaka Y, Ishikawa Y, Lijun Z, Kiguchi H, Ito K et al. Role of macrophage and smooth muscle cell apoptosis in association with oxidized low-density lipoprotein in the atherosclerotic development. Mod Pathol 2005;18:365-373.
45. Escargueil-Blanc I, Meilhac O, Pieraggi MT, Arnal JF, Salvayre R, Negre-Salvayre A. Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway. Prevention by aurintricarboxylic acid. Arterioscler Thromb Vasc Biol 1997;17:331-339.
46. de Souza JA, Vindis C, Hansel B, Negre-Salvayre A, Therond P, Serrano CV Jr et al. Metabolic syndrome features small, apolipoprotein a-i-poor, triglyceride-rich hdl3 particles with defective anti-apoptotic activity. Atherosclerosis 2008;197:84-94.
47. Kontush A, Chantepie S, Chapman MJ. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 2003; 23:1881-1888.
48. Kopprasch S, Pietzsch J, Graessler J. The protective effects of HDL and its constituents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL. Mol Cell Biochem 2004;258:121-127.
49. Liao XL, Lou B, Ma J, Wu MP. Neutrophils activation can be diminished by apolipoprotein A-I. Life Sci 2005;77:325-335.
50. Vaisar T, Mayer P, Nilsson E, Zhao XQ, Knopp R, Prazen BJ. HDL in humans with cardiovascular disease exhibits a proteomic signature. Clin Chim Acta 2010;411:972-979.
51. Bergt C, Fu X, Huq NP, Kao J, Heinecke JW. Lysine residues direct the chlorination of tyrosines in yxxk motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein. J Biol Chem 2004;279:7856-7866.
52. Shao B, Pennathur S, Heinecke JW. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions. J Biol Chem 2012;287:6375-6386.
53. Martinez-Pinna R, Ramos-Mozo P, Madrigal-Matute J, Blanco-Colio LM, Lopez JA, Calvo E et al. Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2011;31:935-943.